Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provid... Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Ensysce's products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. Show more
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.765 | 29.3677204659 | 6.01 | 8.8128 | 5.3401 | 345636 | 6.93736101 | CS |
4 | -0.352 | -4.33124154054 | 8.127 | 9.3 | 5.3401 | 1005871 | 7.53332101 | CS |
12 | 3.725 | 91.975308642 | 4.05 | 14.67 | 2.118 | 28561891 | 8.76928751 | CS |
26 | -0.475 | -5.75757575758 | 8.25 | 14.67 | 2.118 | 14066873 | 8.79354554 | CS |
52 | -8.425 | -52.0061728395 | 16.2 | 30.9 | 2.118 | 7545590 | 9.38434265 | CS |
156 | -10648.225 | -99.9270364114 | 10656 | 25200 | 2.118 | 3408835 | 1122.65815897 | CS |
260 | -57376.225 | -99.9864509271 | 57384 | 61632 | 2.118 | 3463264 | 3065.96566939 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales